Literature DB >> 2957297

Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice.

Y Shimomura, G A Bray, M Lee.   

Abstract

Adrenalectomy in young obese (ob/ob) and the diabetic (db/db) mouse slowed body weight gain. Treatment of adrenalectomized ob/ob mice with cortisone or deoxycorticosterone acetate (DOCA) significantly increased weight gain in a dose-related manner. Cortisone had no effect on weight gain on lean mice and treatment with dehydroepiandrosterone sulfate was without effect on either ob/ob or lean mice. The increment in body weight of adrenalectomized ob/ob mice treated with corticosterone and DOCA was associated with an increase in body weight and an increase in food intake. When adrenalectomy was performed at twenty-three days of age (five days before weaning), animals carrying the (db/db) genotype remained lighter than their normal littermates. These data document the importance of the adrenal gland and its steroids for the development and maintenance of many features of the obese or diabetes mouse.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957297     DOI: 10.1055/s-2007-1011804

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  17 in total

1.  G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome.

Authors:  Ibolya Czegle; Miklós Csala; József Mandl; Angelo Benedetti; István Karádi; Gábor Bánhegyi
Journal:  World J Hepatol       Date:  2012-04-27

Review 2.  Models and mechanisms for hippocampal dysfunction in obesity and diabetes.

Authors:  A M Stranahan
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

Review 3.  Minireview: new molecular mediators of glucocorticoid receptor activity in metabolic tissues.

Authors:  Rucha Patel; Jasmine Williams-Dautovich; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-04-25

4.  Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.

Authors:  Fan Yao; Li Chen; Zheng Fan; Fei Teng; Yali Zhao; Fengying Guan; Ming Zhang; Yanjun Liu
Journal:  Bioorg Med Chem Lett       Date:  2017-07-15       Impact factor: 2.823

5.  Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.

Authors:  Y Wang; Y Nakagawa; L Liu; W Wang; X Ren; A Anghel; K Lutfy; T C Friedman; Y Liu
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

Review 6.  Adaptive thermogenesis in humans.

Authors:  M Rosenbaum; R L Leibel
Journal:  Int J Obes (Lond)       Date:  2010-10       Impact factor: 5.095

7.  Glucocorticoids exacerbate obesity and insulin resistance in neuron-specific proopiomelanocortin-deficient mice.

Authors:  James L Smart; Virginie Tolle; Malcolm J Low
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

8.  Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop.

Authors:  Rucha Patel; Angie L Bookout; Lilia Magomedova; Bryn M Owen; Giulia P Consiglio; Makoto Shimizu; Yuan Zhang; David J Mangelsdorf; Steven A Kliewer; Carolyn L Cummins
Journal:  Mol Endocrinol       Date:  2014-12-11

9.  Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice.

Authors:  Alexis M Stranahan; Kim Lee; Bronwen Martin; Stuart Maudsley; Erin Golden; Roy G Cutler; Mark P Mattson
Journal:  Hippocampus       Date:  2009-10       Impact factor: 3.899

10.  Leptin acts in the periphery to protect thymocytes from glucocorticoid-mediated apoptosis in the absence of weight loss.

Authors:  Robert N Trotter-Mayo; Margo R Roberts
Journal:  Endocrinology       Date:  2008-06-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.